Eksigent (Dublin, California) announced a new distribution agreement with Presearch (Hampshire, United Kingdom). The agreement reportedly covers sales of Eksigent's NanoLC HPLC product line in the United Kingdom and Ireland.
Eksigent announces distribution agreement with Presearch
Eksigent (Dublin, California) announced a new distribution agreement with Presearch (Hampshire, United Kingdom). The agreement reportedly covers sales of Eksigent's NanoLC HPLC product line in the United Kingdom and Ireland.
Presearch specializes in providing solutions and service to analytical and life science research customers. The company's offerings include HPLC, GC, flash chromatography, precision fluid delivery, and organoleptic sensors. Presearch has a base of several hundred customers, including top pharmaceutical companies in the UK.
Waters and Prosolia announce collaboration
Waters Corporation (Milford, Massachusetts) and Prosolia, Inc. (Indianapolis, Indiana) announced a collaboration to develop models of Prosolia's Omni Spray Ion Source that are compatible with Waters mass spectrometers.
The instrument from Prosolia has applications in drug discovery, in situ analysis of biological tissues and other fragile surfaces, as well as in homeland security and environmental monitoring.
"We are delighted with the opportunity to work with Waters in making DESI available for their instruments," stated Kevin Boscacci, president of Prosolia. "Our development time will be cut in half by having Waters support."
Agilent Technologies and Groton Biosystems sign agreement
Agilent Technologies Inc. (Santa Barbara, California) and Groton Biosystems LLC (Boxborough, Massachusetts) announced an agreement to co-market solutions for the Process Analytical Technology (PAT) Initiative for the pharmaceutical industry in the United States and Canada.
PAT is a system for designing, analyzing, and controlling manufacturing by measuring critical quality and performance attributes of raw and in-process materials and processes with the goal of ensuring final product quality.
The alliance is designed to benefit biopharmaceutical customers who perform in-process and final product testing in a wide range of production segments.
The agreement, expected to expand to Europe and Asia in the near future, brings together Agilent's HPLC systems with Groton Biosystems' strong online sampling products and services.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.